A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores

Vera Fridman(Massachusetts General Hospital), Michael E. Shy(University of Iowa), Steven S. Scherer(University of Pennsylvania), Chiara Pisciotta(Fondazione IRCCS Istituto Neurologico Carlo Besta), Mary M. Reilly(University College London), Tiffany Grider(University of Iowa Hospitals and Clinics), Sabrina W. Yum(Children's Hospital of Philadelphia), Giuseppe Piscosquito(University of Salerno), Mario Saporta(University of Miami), Carly E. Siskind(Stanford University), Thomas E. Lloyd(Johns Hopkins University), Rosemary Shy(Wayne State University), John Day(Intermountain Medical Center), Reza Sadjadi(Massachusetts General Hospital), Davide Pareyson, Matilde Laurá(MRC Prion Unit), Emanuela Pagliano(Fondazione IRCCS Istituto Neurologico Carlo Besta), Kimberly Dooley(Children's Hospital Colorado), David Walk(University of Minnesota Medical Center), Gyula Acsádi(Connecticut Children's Medical Center), Shawna Feely(Wayne State University), Isabella Moroni(Vita-Salute San Raffaele University), Richard S. Finkel(Nemours Children's Clinic), Francesco Muntoni(Great Ormond Street Hospital), Richard A. Lewis(Baylor College of Medicine), Janel E. Wilcox(Children's Hospital Colorado), Sarrah A. Knause(Children's Hospital Colorado), Jun Li(Children's Hospital Colorado), David N. Herrmann(University of Rochester Medical Center), Laurie Gutmann(University of Iowa Hospitals and Clinics), Joshua Burns(The University of Sydney), Chelsea Bacon(University of Iowa Hospitals and Clinics), Stephan Züchner(University of Miami), Callyn A. Kirk(University of South Florida), Charlotte J. Sumner(Johns Hopkins University), Stefan Sillau(Kennedy Krieger Institute)
Neurology
February 12, 2020
Cited by 53


Related Papers